Dr. Reddy's Laboratories Limited
237
1
1
227
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.8%
2 terminated/withdrawn out of 237 trials
99.1%
+12.6% vs industry average
10%
23 trials in Phase 3/4
14%
31 of 227 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (237)
A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma
Role: collaborator
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
Role: collaborator
A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.
Role: collaborator
A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)
Role: collaborator
A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma
Role: collaborator
Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma
Role: lead
Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers
Role: collaborator
A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products
Role: lead
Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route
Role: lead
Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks
Role: collaborator
A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects
Role: collaborator
Efficacy, Tolerability, and Safety of DFN-15
Role: collaborator
A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis
Role: lead
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
Role: lead
Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients
Role: lead
Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion
Role: lead
Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers
Role: lead
Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection
Role: lead
Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Role: lead
A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks
Role: lead